Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2007-04-02
2011-10-18
Kim, John (Department: 1777)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C210S201000, C210S203000, C210S295000, C210S435000, C210S500340, C210S500350, C210S503000, C210S645000, C210S646000, C210S660000, C210S679000, C604S004010, C604S005010
Reexamination Certificate
active
08038638
ABSTRACT:
An extracorporeal circuit for removing toxins from the blood and plasma volume control in patients suffering from sepsis and renal failure. The extracorporeal circuit disclosed herein comprises a plasma filter, a toxin removal device and optionally a hemofilter that minimizes electrolyte and protein depletion from the treated plasma while effectively removing both free and protein-bound toxins. The toxin removal device comprises adsorbent materials selected from the group consisting of activated carbon, ion exchange resins and non-ionic exchange resins and the adsorbent materials are coated with albumin. Also provided are associated methods for treating patients suffering from sepsis and renal failure using the disclosed extracorporeal circuit and toxin removal device.
REFERENCES:
patent: 3442819 (1969-05-01), Herbert
patent: 3725113 (1973-04-01), Chang
patent: 4127481 (1978-11-01), Malchesky et al.
patent: 4209392 (1980-06-01), Wallace
patent: 4231871 (1980-11-01), Lipps et al.
patent: 4267047 (1981-05-01), Henne et al.
patent: 4269706 (1981-05-01), Sondermann
patent: 4617115 (1986-10-01), Vantard
patent: 4747822 (1988-05-01), Peabody
patent: 4769037 (1988-09-01), Midcalf
patent: 4988569 (1991-01-01), Okazaki et al.
patent: 5015388 (1991-05-01), Pusineri et al.
patent: 5091091 (1992-02-01), Terman
patent: 5108612 (1992-04-01), Flaig et al.
patent: 5194157 (1993-03-01), Ghezzi et al.
patent: 5232843 (1993-08-01), Bosley et al.
patent: 5240601 (1993-08-01), Mazid
patent: 5571418 (1996-11-01), Lee et al.
patent: 5679260 (1997-10-01), Boos et al.
patent: 5744042 (1998-04-01), Stange et al.
patent: 6287516 (2001-09-01), Matson et al.
patent: 6730266 (2004-05-01), Matson et al.
patent: 6736972 (2004-05-01), Matson
patent: 6787040 (2004-09-01), Radunsky et al.
patent: 2004/0173530 (2004-09-01), Radunsky et al.
patent: 2004/0228829 (2004-11-01), Roberts et al.
patent: 2005/0169889 (2005-08-01), Buasen et al.
patent: 31 10128 (1982-09-01), None
patent: 0 787 500 (1997-08-01), None
patent: 00/02603 (2000-01-01), None
patent: 03/009885 (2003-02-01), None
Anand, A.C., “Early Indicators of Prognosis in Fulminant Hepatic Failure: An Assessment of the King's Criteria”, J. Hepatology, 1997, vol. 26, pp. 62-66.
Ash, S.R., “Treatment of Acute Hepatic Failure with Encepthalopahy: A Review”, Int., J. Artif. Organs, 1991, vol. 14, pp. 191-195.
Awad, S.S., et al., “A Novel Stable Reproducible Model of Hepatic Failure in Canines”, Journal of surgical Research, 2000, vol. 94, pp. 167-171.
Bende, S. et al., “Elimination of Endotoxin from the Blood by Extracorporeal Activated Charcoal Hemoperfusion in Experimental Canine Endotoxin Shock”, Circulatory Shock, 1986, vol. 19, pp. 239-244.
Ellis, A.J., et al., “Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the BioLogic-DT”, Int. J. Artif. Organs, 1999, vol. 22, pp. 27-34.
Falkenhagen, D. et al., “Fractionated Plasma Separation and Adsorption System: A Novel System for Blood Purification to Remove Albumin Bound Substances”, Artif. Organs, 1999, vol. 23, pp. 81-86.
Hughes, R. et al., “Use of Sorbent Columns and Haemofiltration in Fulminant Hepatic Failure”, Bolld, Purif., 1993, vol. 11, pp. 163-169.
Hughes, R.D., et al., “Artificial Liver Support in Acute Liver Failure: A Review of Studies at King's”, Artif. Organs, 1992, vol. 16, pp. 167-170.
Hughes, R.D., et al., “In-Vitro Blood Compatibility Studies on a New Polymer-Coated Charcoal for Haemoperfusion”, The International Journal of Artificial Organs, 1980, vol. 3, No. 5, pp. 277-279.
Hughes, R.D., et al., “Platelet Function during Haemoperfusion in Acute Liver Failure”, The International Journal of Artificial Organs, 1980, vol. 3, No. 1, pp. 30-34.
Kellum, J. A., et al., “Effect of Hemofiltration Filter Adsorption on circulating IL-6 Levels in Septic Rats”, Critical Care, 2002, vol. 6, pp. 429-433.
Makin, A.J., et al., “Systemic and Hepatic Hemodynamic Changes in Acute Liver Injury”, The American Physiological Societey, 1997, vol. 272, pp. G617-G625.
Morimoto, T., et al., “Plasma Adsorption Using Bilirubin-Adsorbent Materials as a Treatment for Patients with Hepatic Failure”, Artificial Organs, 1989, pp. 447-452.
Mullen, K., et al., “Hepatic Encephalopahy”, Schiff's Diseases of the Liver, Eighth-Edition, Lippincot-Raven Publishers, Philadelphia, 1999, pp. 545-581.
Nagaki, M., et al., “In Vitro Plasma Perfusion Through Adsorbents and Plasma Ultrafiltration to Remove Endotoxin and Cytokines”, Circulatory Shock, 1992, vol. 38, pp. 182-188.
Nagaki, M., et al., “Removal of Endotoxin and Cytokines by Adsorbents and the Effect of Plasma Protein Binding”, Liver Unit, King's College School of Medicine and Dentistry, 1991, vol. 4 pp. 43-50.
Nakae, H., et al., “Effectiveness of Combining Plasma Exchange and Continuous Hemodiafiltration (Combined Modality Therapy in a Parallel Circuit) in the Treatment of Patients wit Acute Hepatic Failure”, Therapeutic Apheresis, 2001, vol. 5, No. 6, pp. 471-475.
Odnopozov, V. A., “Effect of Hemocarboperfusion on Organ Blood Flow and Survival in Porcine Endotoxic Shock”, Critical Care Med., 1996, vol. 24, No. 12, pp. 2020-2026.
Peltekian, K. et al., “Role of Cytokines and Immune Mechanisms in Acute Liver Failure”, Edited by Lee WM et al,, (eds), Cambridge Press, 1997, pp. 67-78.
Rahman, T.M., et al., “Review Article: Liver Support Systems in Acute Hepatic Failure”, Aliment Pharmacol Ther, 1999, vol. 13, pp. 1255-1272.
Ronco, C., et al., “A Pilot Study of Coupled Plasma Filtration with Adsorption in Septic Shock”, Critical Care Med. 2002, vol. 30, No. 6, pp. 1250-1255.
Ryan, C.J., et al., “Preclinical Evaluation of Haemoorbents”, The International Journal of Artificial Organs, 1986, vol. 9, No. 5, pp. 293-296.
Ryan, C.J., et al., “Repeated Membrane Plasma Separation wit On-Line Sorbent Treatment of Plasma in the Conscious Rat”, Artificial Organs, 1986, vol. 10, No. 2, pp. 135-144.
Schiodt, F.V., et al., “Etiology and Outcome for 295 Patients with Acute Liver Failure in the United States”, Liver Transplantation and Surgery, vol. 5, No. 1 , Jan. 1999, pp. 29-34.
Schodt, F.V., et al., “Acetaminophen Toxicity in an Urban County Hospital”, The New England Journal of Medicine, Oct. 16, 1997, vol. 337, No. 16, pp. 1112-1117.
Strange, J. et al., “Liver Support by Extracorporeal Blood Purification—A Clinical Observation”, German Ministry for Research and Technology, Germany, 2000, vol. 6, No. 5, pp, 603-613.
Sudan, D.L., et al., “Long-Term Follow-up of Auxiliary Orthotopic Liver Transplantation for the Treatment of Fulminant Hepatic Failure”, Surgery, 1997, vol. 122, No. 4, pp. 777-778.
Sussman, N.L., et al., “Reversal of Fulminant Hepatic Failure Using an Extracorporeal Liver Assist Device”, Hepatology, 1992, vol. 16, No. 1, pp. 60-65.
Terblanche, J. et al., “Animal Models of Fulminant Hepatic Failure”, Digestive Diseases and Sciences, 1991, vol. 26, No. 6, pp. 770-774.
Tetta, C., et al., “Endotoxin and Cytokine Removal in Sepsis”, Ther. Apher., 2002, vol. 6, No. 2, pp. 109-115.
Wendon, J.A., et al., “Cerebral Blood Flow and Metabolism in Fulminant Liver Failure”, Hepatology, 1994, vol. 19, pp. 1407-1413.
Wehler, M. et al., “Short-Term Prognosis in Critically Ill Patients with Cirrhosis Assessed by Prognostic Scoring Sytems”, Hepatology, 2001, vol. 34, pp. 255-261.
Williams, R., “New Directions in Acute Liver Failure”, Journal of the Regal College of Physicians of London, 1994, vol. 28, No. 6, pp. 552-559.
Venkataraman, R., et al., “Clinical Review: Extracorporeal Blood Purification in Severe Sepsis”, Critical Care, 2003, vol. 7, No. 2, pp. 139-145.
Angus, D.C., et al., “Epid
Litzie Ken
Roberts Craig P.
Bergman Michelle Glasky
Cullman Louis C.
Hemolife Medical, Inc.
K&L Gates LLP
Kim John
LandOfFree
Plasma detoxification and volume control system and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasma detoxification and volume control system and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasma detoxification and volume control system and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295832